November 1, 2022
FDA: Five companies are having amoxicillin shortages
Editor's Note
As of November 1, the Food and Drug Administration (FDA) listed 26 amoxicillin products on its current drug shortages site. The FDA says increased demand is the largest cause of the shortage.
The FDA does not list resupply dates, but the American Society of Health-System Pharmacists (ASHP) estimates resupply dates for Hikma products (August 2023), Sandoz products (cannot estimate a release date), and Teva products (November and December 2022).
Free Daily News
- ACS conference charts bold future for surgical quality with data, teamwork, frontline innovation
- Surgical leaders urged to weigh risks, rewards of innovation with a critical eye
- Health systems report dramatic nurse retention gains through residency, development programs
- Surgical innovation redefines what is possible for advanced colorectal cancer
- CMS proposal to end inpatient only list draws strong industry response
- Fall deaths among older adults have tripled, prescription drugs under scrutiny
- AI could shrink drug discovery from years to months, expert says
- AI vendors bet on guaranteed ROI as competition with Epic intensifies
- AMA 2026 CPT code set expands with AI, remote monitoring, leg revascularization updates
- PACU initiative cuts emergency response times from 9 to 2 minutes
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement